UPDATE: Goldman Sachs Reiterates Neutral Rating, Raises PT on Team Health Holdings on Solid Q4 Results

In a report published Friday, Goldman Sachs reiterated its Neutral rating on Team Health Holdings (NYSE: TMH ), and raised its price target from $30.00 to $33.00. Goldman Sachs noted, “TMH reported 4Q EPS of $0.39 vs. our/Street estimate of $0.40/$0.36 with revenues and adjusted EBITDA largely in line with